Abstract:PurposeG Protein-Coupled Receptors (GPCRs) are a large family of therapeutically important proteins and as diverse X-ray structures become available it is increasingly possible to leverage structural information for rational drug design.We present herein approaches that use explicit water networks combined with energetic surveys of the binding site (GRID), providing an enhanced druggability and ligand design approach, with structural understanding of ligand binding, including a ‘magic’ methyl and binding site mutations, and a fast new approach to generate and score waters.MethodsThe GRID program was used to identify lipophilic and hydrogen bonding hotspots. Explicit full water networks were generated and scored for (pseudo)apo structures and ligand-protein complexes using a new approach, WaterFLAP (Molecular Discovery), together with WaterMap (Schrödinger) for (pseudo)apo structures. A scoring function (MetaScore) was developed using a fast computational protocol based on several short adiabatic biased MD simulations followed by multiple short well-tempered metadynamics runs.ResultsAnalysis of diverse ligands binding to the adenosine A2A receptor together with new structures for the δ/κ/μ opioid and CCR5 receptors confirmed the key role of lipophilic hotspots in driving ligand binding and thus design; the displacement of ‘unhappy’ waters generally found in these regions provides a key binding energy component. Complete explicit water networks could be robustly generated for protein-ligand complexes using a WaterFLAP based approach. They provide a structural understanding of structure-activity relationships such as a ‘magic methyl’ effect and with the metadynamics approach a useful estimation of the binding energy changes resulting from active site mutations.ConclusionsThe promise of full structure-based drug design (SBDD) for GPCRs is now possible using a combination of advanced experimental and computational data. The conformational thermostabilisation of StaR® proteins provide the ability to easily generate biophysical screening data (binding including fragments, kinetics) and to get crystal structures with both potent and weak ligands. Explicit water networks for apo and ligand-complex structures are a critical ‘third dimension’ for SBDD and are key for understanding ligand binding energies and kinetics. GRID lipophilic hotspots are found to be key drivers for binding. In this context ‘high end’ GPCR ligand design is now enabled.

Fine-tuning activation specificity of G-protein-coupled receptors via automated path searching

Fragment-Based Computational Method for Designing GPCR Ligands

Molecular Recognition of Metabotropic Glutamate Receptor Type 1 (mglur1): Synergistic Understanding with Free Energy Perturbation and Linear Response Modeling

Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.

Computational structural-based GPCR optimization for user-defined ligand: Implications for the development of biosensors

Precise modelling and interpretation of bioactivities of ligands targeting G protein-coupled receptors.

Conformational and Thermodynamic Landscape of GPCR Activation from Theory and Computation

High end GPCR design: crafted ligand design and druggability analysis using protein structure, lipophilic hotspots and explicit water networks

Higher-Affinity Agonists of 5-HT1AR Discovered Through Tuning the Binding-Site Flexibility

Design of allosteric modulators that change GPCR G protein subtype selectivity

Molecular Docking and Molecular Dynamics Simulation Studies of GPR40 Receptor–agonist Interactions

Novel Scaffold Agonists of the α2A Adrenergic Receptor Identified via Ensemble-Based Strategy

Activation Pathway of a G Protein-Coupled Receptor Uncovers Conformational Intermediates As Targets for Allosteric Drug Design

A Hybrid Approach to Structure and Function Modeling of G Protein-Coupled Receptors

Integrating Pharmacophore Into Membrane Molecular Dynamics Simulations To Improve Homology Modeling Of G Protein-Coupled Receptors With Ligand Selectivity: A(2a) Adenosine Receptor As An Example

A chromatographic method for pursuing potential GPCR ligands with the capacity to characterize their intrinsic activities of regulating downstream signaling pathway

Characterization of Ligand Binding to GPCRs Through Computational Methods

Selective Activation of GPCRs: Molecular Dynamics Shows Siponimod Binds but Fails to Activate S1PR2 Unlike S1PR1

Discovery of GPCR ligands for probing signal transduction pathways

Structural Basis of Sphingosine-1-phosphate Receptor 1 Activation and Biased Agonism

Structural insights into sphingosine 1-phosphate receptor 4 activation